Company: NDRA
Filing Date: 2025-07-09
Form Type: S-1
Source: 0001654954-25-007870
Chunk: 20

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-09
Form: S-1
Chunk 20
---
 | authorize our board of directors to issue preferred stock without stockholder approval and to designate the rights, preferences and privileges of each class; if issued, such preferred stock would increase the number of outstanding shares of our capital stock and could include terms that may deter an acquisition of us; |
| · | limit who may call stockholder meetings;                                                                                                                                                                                                                                                                                        |
| · | do not provide for cumulative voting rights;                                                                                                                                                                                                                                                                                    |
| · | provide that all vacancies in our board of directors may be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;                                                                                                                                                               |
| · | provide that stockholders must comply with advance notice procedures with respect to stockholder proposals and the nomination of candidates for director;                                                                                                                                                                       |
| · | provide that stockholders may only amend our Certificate of Incorporation upon a supermajority vote of stockholders; and                                                                                                                                                                                                        |
| · | provide that the Court of Chancery of the State of Delaware will be the exclusive forum for certain legal claims.                                                                                                                                                                                                               |

In addition, section 203 of the Delaware General Corporation Law limits our ability to engage in any business combination with a person who beneficially owns 15% or more of our outstanding voting stock unless certain conditions are satisfied. This restriction lasts for a period of three years following any such person’s share acquisition. These provisions may have the effect of entrenching our management team and may deprive stockholders of the opportunity to sell their shares to potential acquirers at a premium over prevailing prices. This potential inability to obtain a control premium could reduce the price of our common stock.

| 18 |

As an investor, you may lose all of your investment.

Investing in our securities involves a high degree of risk. As an investor, you may never recoup all, or even part, of your investment and you may never realize any return on your investment. You must be prepared to lose all of your investment.

Our management will have broad discretion over the portion of the net proceeds of this offering that are not being used to establish the Company’s cryptocurrency treasury operation,which we may not use effectively or in a manner with which you agree.

Our management will have broad discretion as to the use of the portion of net proceeds from this offering that are not being used to establish the Company’s cryptocurrency treasury operation and could use them for purposes other than those contemplated at the time of this offering. Accordingly, you will be relying on the judgment of our management with regard to the use of these net